224 related articles for article (PubMed ID: 31172216)
1. Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.
Nekoua MP; Bertin A; Sane F; Alidjinou EK; Lobert D; Trauet J; Hober C; Engelmann I; Moutairou K; Yessoufou A; Hober D
Cell Mol Life Sci; 2020 Jan; 77(1):179-194. PubMed ID: 31172216
[TBL] [Abstract][Full Text] [Related]
2. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.
Hober D; Sane F; Jaïdane H; Riedweg K; Goffard A; Desailloud R
Clin Exp Immunol; 2012 Apr; 168(1):47-51. PubMed ID: 22385236
[TBL] [Abstract][Full Text] [Related]
3. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.
Engelmann I; Alidjinou EK; Bertin A; Bossu J; Villenet C; Figeac M; Sane F; Hober D
Cell Mol Life Sci; 2017 Oct; 74(20):3851-3861. PubMed ID: 28601984
[TBL] [Abstract][Full Text] [Related]
4. Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.
Nekoua MP; Yessoufou A; Alidjinou EK; Badia-Boungou F; Moutairou K; Sane F; Hober D
Acta Diabetol; 2018 Aug; 55(8):827-834. PubMed ID: 29774468
[TBL] [Abstract][Full Text] [Related]
5. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
6. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.
Jaïdane H; Caloone D; Lobert PE; Sane F; Dardenne O; Naquet P; Gharbi J; Aouni M; Geenen V; Hober D
J Virol; 2012 Oct; 86(20):11151-62. PubMed ID: 22855493
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?
El-Senousy WM; Abdel-Moneim A; Abdel-Latif M; El-Hefnawy MH; Khalil RG
Food Environ Virol; 2018 Mar; 10(1):89-98. PubMed ID: 29022248
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.
Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D
Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573
[TBL] [Abstract][Full Text] [Related]
9. Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells.
Nekoua MP; Dechaumes A; Sane F; Alidjinou EK; Moutairou K; Yessoufou A; Hober D
Microorganisms; 2020 Jul; 8(7):. PubMed ID: 32630332
[TBL] [Abstract][Full Text] [Related]
10. Enteroviral infections and development of type 1 diabetes: The Brothers Karamazov within the CVBs.
Dotta F; Sebastiani G
Diabetes; 2014 Feb; 63(2):384-6. PubMed ID: 24464713
[No Abstract] [Full Text] [Related]
11. Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.
Bertin A; Sane F; Gmyr V; Lobert D; Dechaumes A; Kerr-Conte J; Pattou F; Hober D
Viruses; 2019 Jul; 11(7):. PubMed ID: 31269669
[TBL] [Abstract][Full Text] [Related]
12. Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.
Badia-Boungou F; Sane F; Alidjinou EK; Ternois M; Opoko PA; Haddad J; Stukens C; Lefevre C; Gueorguieva I; Hamze M; Ismail M; Weill J; Monabéka HG; Bouenizabila E; Moukassa D; Abena AA; Hober D
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719027
[TBL] [Abstract][Full Text] [Related]
13. Enhancing and neutralizing anti-coxsackievirus activities in serum samples from patients prior to development of type 1 diabetes.
Sane F; Bertin A; Sioofy-Khojine AB; Oikarinen S; Alidjinou EK; Veijola R; Toppari J; Ilonen J; Knip M; Engelmann I; Hyöty H; Hober D
Diabetes Metab Res Rev; 2020 Sep; 36(6):e3305. PubMed ID: 32118346
[TBL] [Abstract][Full Text] [Related]
14. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.
Dotta F; Censini S; van Halteren AG; Marselli L; Masini M; Dionisi S; Mosca F; Boggi U; Muda AO; Del Prato S; Elliott JF; Covacci A; Rappuoli R; Roep BO; Marchetti P
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5115-20. PubMed ID: 17360338
[TBL] [Abstract][Full Text] [Related]
15. Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.
Elmastour F; Jaïdane H; Benkahla M; Aguech-Oueslati L; Sane F; Halouani A; Engelmann I; Bertin A; Mokni M; Gharbi J; Aouni M; Alidjinou EK; Hober D
Virulence; 2017 Aug; 8(6):908-923. PubMed ID: 27792461
[TBL] [Abstract][Full Text] [Related]
16. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4.
Goffard A; Alidjinou EK; Sané F; Choteau L; Bouquillon C; Caloone D; Lobert PE; Hober D
Microbes Infect; 2013 Jan; 15(1):18-27. PubMed ID: 23108316
[TBL] [Abstract][Full Text] [Related]
17. Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation.
Nekoua MP; Bertin A; Sane F; Gimeno JP; Fournier I; Salzet M; Engelmann I; Alidjinou EK; Hober D
Microorganisms; 2021 May; 9(6):. PubMed ID: 34067388
[TBL] [Abstract][Full Text] [Related]
18. Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.
Jaïdane H; Sané F; Hiar R; Goffard A; Gharbi J; Geenen V; Hober D
Clin Exp Immunol; 2012 Apr; 168(1):39-46. PubMed ID: 22385235
[TBL] [Abstract][Full Text] [Related]
19. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.
Jaïdane H; Sauter P; Sane F; Goffard A; Gharbi J; Hober D
Rev Med Virol; 2010 Sep; 20(5):265-80. PubMed ID: 20629044
[TBL] [Abstract][Full Text] [Related]
20. Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic α and β cells.
Marroqui L; Lopes M; dos Santos RS; Grieco FA; Roivainen M; Richardson SJ; Morgan NG; Op de Beeck A; Eizirik DL
Elife; 2015 Jun; 4():e06990. PubMed ID: 26061776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
